Filing Details
- Accession Number:
- 0001225208-15-005501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-24 19:08:50
- Reporting Period:
- 2015-02-20
- Filing Date:
- 2015-02-24
- Accepted Time:
- 2015-02-24 19:08:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1271440 | S Christopher Holland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Senior Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-20 | 7,940 | $95.99 | 33,611 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-02-20 | 3,500 | $97.69 | 37,111 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-20 | 450 | $176.69 | 36,661 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-20 | 15,641 | $176.01 | 21,020 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2015-02-20 | 7,940 | $0.00 | 7,940 | $95.99 |
Common Stock | Option (Right to Buy) | Disposition | 2015-02-20 | 3,500 | $0.00 | 3,500 | $97.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,941 | 2022-06-01 | No | 4 | M | Direct | |
20,410 | 2022-12-12 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for price increments ranging from $176.67 to $176.71. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $175.66 to $176.60. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant, 7,940 options vested on June 1, 2014 and the remaining options vest in two equal annual installments beginning on June 1, 2015.
- Of this option grant, 11,955 options vested on December 12, 2014 and the remaining options vest in two equal annual installments beginning on December 14, 2015.